Pirjo Kortesuo has 30 years experience in Pharmaceutical industry in Finland. 

She obtained her M.Sc. in Biochemistry from the University of Turku and Ph.D. in Pharmacy from the University of Helsinki, followed by Ph.D. studies at Orion Corporation, Finland.

Her research focused on the utilization of biodegradable silica matrix as a drug carrier system. Following the successful completion of her Ph.D., she transitioned to Bayer Oy (previously known as Bayer Schering Pharma and Leiras), where she dedicated a significant portion of her professional life.

At Bayer Oy, Pirjo primarily focused on the development of intrauterine devices (IUDs) for women’s health. She has a solid expertise of the entire product development process, from early feasibility and compatibility assessments to submission and transfer to production including the manufacturing of investigational medicinal products for clinical trials.

Additionally, Pirjo has a strong knowledge of regulatory and quality requirements for combination products. Throughout her career, Pirjo has established a wide network of connections with Finnish universities and research centers. Additionally she has also pursued studies in leadership at Bayer Academy.